Emerald Advisers, LLC Edwards Lifesciences Corp Transaction History

Emerald Advisers, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 31, 2019	SELL	$61.55 - $75.43 $175,971 - $215,654	-2,859 Closed	0 $0
Q2 2019 Jul 31, 2019	SELL	$55.74 - $64.41 $78,537 - $90,753	-1,409 Reduced 33.01%	2,859 $528,000
Q1 2019 May 01, 2019	SELL	$47.89 - $64.05 $1,101 - $1,473	-23 Reduced 0.54%	4,268 $817,000
Q4 2018 Jan 30, 2019	SELL	$46.41 - $56.94 $103,633 - $127,147	-2,233 Reduced 34.23%	4,291 $657,000
Q3 2018 Oct 31, 2018	SELL	$45.7 - $58.03 $10,648 - $13,520	-233 Reduced 3.45%	6,524 $1.14 Million
Q2 2018 Jul 31, 2018	SELL	$42.45 - $51.3 $9,254 - $11,183	-218 Reduced 3.13%	6,757 $984,000
Q1 2018 Apr 26, 2018	SELL	$37.19 - $47.45 $26,330 - $33,594	-708 Reduced 9.22%	6,975 $973,000
Q4 2017 Feb 05, 2018	SELL	$33.79 - $39.39 $14,022 - $16,346	-415 Reduced 5.12%	7,683 $866,000
Q3 2017 Oct 30, 2017	BUY	$36.29 - $38.83 $293,876 - $314,445	8,098	8,098 $885,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Emerald Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Emerald Advisers, LLC with notifications on news.